Drug Discovery World interviews Milner Institute Head of Research
Earlier this year, our Head of Research Dr Nicola McCarthy sat down with Megan Thomas, Multimedia Editor at Drug Discovery World, to explore Nicola’s role at the MTI, her career journey, and her views on the current opportunities and challenges in the field of drug...
Cambridge Biomedical Campus welcomes Milner Affiliate Cytiva
Global life sciences leader and Milner affiliate Cytiva recently established a footprint in the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus (CBC), further developing relationships with the Milner Institute and the Cambridge Stem Cell Institute...
Milner Institute celebrates success of 2024 Pitch Day and Therapeutics Symposium
Last week, we were delighted to host two sell-out events in Cambridge that brought academics, investors, pharma and biotech companies together. On 1st July, we hosted our Milner Pitch Day at St Catharine’s College, which aimed to accelerate innovative ideas toward...
Milner welcomes Flagship Pioneering to learn more about the Institute’s unique model
We were delighted to welcome Flagship Pioneering to the Milner Therapeutics Institute this week. Noubar Afeyan and colleagues from Flagship visited the Institute to learn more about the Milner model and discuss how we might work together in future. It was fantastic to...
Milner Director Tony Kouzarides awarded a knighthood in the King’s Birthday Honours List
We are delighted to share that our Director, Professor Sir Tony Kouzarides – a Professor of Cancer Biology at the University of Cambridge and a Senior Group Leader at the Gurdon Institute – has been awarded a knighthood for his services to healthcare innovation and...
Milner collaboration develops organoid assays that could help identify new treatments for Crohn’s disease
Work at the Milner Therapeutics Institute in collaboration with Professor Matthias Zilbauer has made a promising step toward identifying more precise and personalised treatments for patients with Crohn’s disease. The research published today in Gut reports how Milner...
Chun Hao Wong joins the Milner Institute as Lead for Functional Genomics Screening Lab
We are delighted to announce that Chun Hao Wong has joined the Milner team as the MTI lead for the new MRC-AstraZeneca-University of Cambridge Functional Genomics Screening Laboratory (FGSL). The FGSL aims to combine know-how and experience to accelerate the...
Milner Institute showcases in-house research at the Cambridge Festival
This year the Milner Institute was delighted to take part in the University of Cambridge’s interdisciplinary Cambridge Festival. The Festival takes place each Spring and includes a mixture of online, on-demand and in-person events covering all aspects of the...